Included in the formulation
АТХ:L.03 Immunostimulators
Pharmacodynamics:Immunomodulating drug of bacterial origin. Modulates the immune response of the body, stimulates cellular and humoral immunity.
Reduces the frequency and severity of infections, thereby reducing the need for antibiotics.
Pharmacokinetics:Not studied.
Indications:- infectious diseases of the respiratory tract (as part of complex therapy as an immunomodulating agent) in children aged 6 months to 12 years (for capsules 3.5 mg);
- infectious diseases of the respiratory tract (as part of complex therapy as an immunomodulating agent) in adults and children over the age of 12 (capsules 7 mg);
- for the prevention of recurrent infections of the upper and lower divisions of the respiratory tract (chronic bronchitis, tonsillitis, pharyngitis, laryngitis, rhinitis, sinusitis, otitis).
VIII.H65-H75.H66 Purulent and unspecified otitis media
X.J00-J06.J00 Acute nasopharyngitis (runny nose)
X.J00-J06.J01 Acute Sinusitis
X.J00-J06.J02 Acute pharyngitis
X.J00-J06.J03 Acute tonsillitis
X.J00-J06.J04 Acute laryngitis and tracheitis
X.J30-J39.J31 Chronic rhinitis, nasopharyngitis and pharyngitis
X.J30-J39.J32 Chronic Sinusitis
X.J30-J39.J35.0 Chronic tonsillitis
X.J30-J39.J37 Chronic laryngitis and laryngotracheitis
X.J40-J47.J42 Chronic bronchitis, unspecified
Contraindications:- Hypersensitivity to the components of the drug.
- Children under 6 months.
Pregnancy and lactation:The use of the drug during pregnancy and during lactation is possible only if the intended benefit to the mother exceeds the potential risk to the fetus or baby.
FDA recommendations are not defined.
Dosing and Administration:Adults and children over 12 years of age the drug is prescribed in a dose of 7 mg; Children aged 6 months to 12 years in a dose of 3.5 mg.
For the prevention of infectious diseases of the respiratory tract, the drug is used for three 10-day courses with 20-day intervals between them.
In the acute period of the disease, 1 capsule is prescribed per day until the symptoms disappear, but not less than 10 days. In the next 2 months, preventive use of the drug for 1 capsule for 10 days with a 20-day interval between courses is possible.
Side effects:During the entire period of clinical use of the drug, undesirable effects were recorded extremely rarely.
In some cases: violations of the digestive system (pain in the epigastrium, nausea, vomiting, diarrhea), increased body temperature.
If the side effects are mild, no drug withdrawal is required. If a hypersensitivity reaction occurs, it is recommended that the drug be withdrawn.
Overdose:No clinical symptoms of an overdose were noted. No reports of intoxication due to drug overdose.
Interaction:The drug can be used concomitantly with other medicines, including antibiotics.
Special instructions:Between the use of oral vaccines and taking the drug should be observed a four-week interval.
Do not recommend the use of the drug in acute intestinal diseases because of a possible decrease in the effectiveness of the drug.
The drug is not prescribed for children under 6 months.
To avoid overdose to children from 6 months to 12 years, the drug is prescribed in the form of capsules containing 3.5 mg of lyophilizate.
Does not affect the ability to drive vehicles and control mechanisms.